secwatch.observer — SEC 8-K summary
======================================

Issuer:     PMV Pharmaceuticals, Inc. (PMVP)
CIK:        0001699382
Form:       8-K
Filed at:   2023-10-11T23:59:59+00:00
Accession:  0001193125-23-254135
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PMV Pharma to present updated Phase 1 PC14586 data at AACR-NCI-EORTC; KOL webinar planned
--------------------------------------------------------------------------------

- Updated Phase 1 data cutoff Sep 5, 2023; abstract with May 1 cutoff published.
- Poster session October 12, 2023 12:30-4:00 PM ET at AACR-NCI-EORTC conference.
- PC14586 targets p53 Y220C mutation in advanced solid tumors; PYNNACLE study ongoing.
- KOL webinar October 12 at 4:00 PM ET with regulatory update included.
- Data also discussed in Chemistry in Cancer Research Town Hall and Concurrent Session 8.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1699382/000119312523254135/0001193125-23-254135-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1699382/000119312523254135/d516537d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-254135

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer